ISEPK ULiège
Liège, 4000, Belgium
NCT Number: NCT04005846
Many different factors affect running performance, transcranial direct current stimulation (tDCS) is a widely used and available neuromodulation tool and could hypothetically facilitate the supraspinal drive and thereby act upstream of the motor cortex to prolong the muscles work in time to exhaustion trials. While it appears to decrease the rating of perceived exertion (RPE) during cycling, little is known about the effects of tDCS on physiological performance parameters such as maximal oxygen consumption (VO2max), maximal aerobic speed (MAS) and lactate thresholds in runners.
The aim of this prospective randomized sham-controlled clinical trial is to investigate the physiological effects of tDCS applied over the motor cortex on perceived exertion and performance-related parameters measured by an incremental treadmill test to exhaustion.
This research thus aims at answering the following questions:
1. Is active tDCS applied bilaterally over the motor cortex significantly more efficient than sham tDCS to improve the TTE? 2. Does active tDCS decreases the RPE, as compared to sham? 3. Is there any significant difference between active and sham tDCS on the physiological parameters measured during an incremental test to exhaustion, namely: VO2max, MAS, respiratory exchange ratio, blood lactate levels, maximal heart rate? 4. Does the baseline level of physical fitness influences response to tDCS?
The investigators hypothesize that 1) performance as measured by time to exertion will be increased following active and not sham tDCS due to a decreased perceived rate of exertion without significantly altering the other physiological parameters; and 2) performance as measured by incremental treadmill test to exhaustion will be more improved in recreational as compared to trained runners.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Phase 1 / Phase 2
Liège, 4000, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The active session of tDCS will consist in applying two anodes over M1 bilaterally (C3 and C4 according to the 10-20 international EEG placement) and the cathodes over the occipital areas (O1 and O2), and to inject 2 mA for 20 minutes through sponge electrodes (35 cm²) placed on the scalp using the Startsim 8 (Neuroelectrics, Barcelona). The sham tDCS will use the same montage and device but direct current will only be injected for 30 seconds, with a ramp-up and ramp-down 15 seconds period, to mimic the somatosensory effects of active tDCS.
Time frame: Immediate
Time to achieve exhaustion during a treadmill test where the speed is set at a constant 90% of the individual maximal aerobic speed (determined during the screening visit)
Time frame: Every 3 minutes during the test to exhaustion until the end of the test (up to 1 hour after the stimulation)
RPE will be assessed continuously (every 3 minutes) during the time to exhaustion trial using the Borg rating of perceived exertion scale (RPE scale). The Borg RPE scale is a quantitative measure of perceived exertion during physical activity. The scale starts with "no feeling of exertion," which rates a 6, and ends with "very, very hard," which rates a 20. Moderate activities register 11 to 14 on the Borg scale ("fairly light" to "somewhat hard"), while vigorous activities usually rate a 15 or higher ("hard" to "very, very hard").
Time frame: Immediate
VO2max will be assessed continuously during the time to exhaustion trial using a gas analyzer
Time frame: Every 3 minutes during the test to exhaustion until the end of the test (up to 1 hour after the stimulation)
Levels of blood lactate will be measured continuously (every 3 minutes) during the time to exhaustion trial using capillary blood and a lactate analyzer
University of Liege
Other
Transcranial Direct Current Stimulation (tDCS) to Improve Maximal Aerobic Performance in Recreational and Trained Runners
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07727850
Athletic Performance
Denizli, Pamukkale, Turkey (Türkiye)
View Trial DetailsNCT07731464
Anxiety, Anxiety Disorders
Islamabad, Federal, Pakistan
View Trial DetailsNCT07726979
Athletic Performance, Bone Metabolism
Surabaya, Jawa Timur - East Java, Indonesia
View Trial DetailsNCT07482254
Athletic Performance, Isometric Strength Training
Katowice, Silesian Voivodeship, Poland
View Trial Details